HopeStage
Back to all studies
CompletedNCT06190483

Diazepam and brain chemistry related to psychosis risk

About this titleRead the official source — NCT06190483
Medication studyAges 18–40United KingdomSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 40 years.

Listed locations
LondonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 24, 2019
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
King's College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United Kingdom
Age range
From 18 Years to 40 Years
Official registry ID
NCT06190483
Official title
Show the full official title

Effect of Benzodiazepine on Corticolimbic Activation, GABA and Glutamate in Subjects at Clinical High Risk of Psychosis

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is King's College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Diazepam 5 Mg Oral Tablet and Ascorbic Acid 50 Mg Oral Tablet.

Who was this study for?

Listed age limits: 18 years to 40 years.

Want to explore more studies?

Explore studies